Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aclaris Therapeutics (GB:0H8T)
LSE:0H8T
Aclaris Therapeutics (0H8T) Ownership - Who Owns Aclaris Therapeutics?
0 Followers
Aclaris Therapeutics (0H8T) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
13.19% Other Institutional Investors
86.81% Public Companies and
Individual Investors
The ownership structure of Aclaris Therapeutics (GB:0H8T) stock is a mix of institutional, retail and individual investors. Approximately 13.19% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 86.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 05, 2024 | Powell Andrew Kenneth William Director | Bought | $17955 |
| Sep 07, 2023 | Bought | $74971 | |
| Aug 28, 2023 | James Loerop Cbo | Bought | $99847 |
| Jun 22, 2023 | Christopher P. Molineaux Director | Bought | $23265 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Sold | $13684 | |
| Dec 31, 2023 | Bought | $21000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2 | Institution | ― | 2 | |
| 3,358,043 | Institution | ― | 3,979,281 | |
| 3,008,223 | Institution | ― | 3,564,744 | |
| 16,206 | Institution | ― | 19,204 | |
| 260,151 | Institution | ― | 308,279 | |
| 4,283 | Institution | ― | 5,076 | |
| 78,370 | Institution | ― | 92,868 | |
| 185,411 | Institution | ― | 219,712 | |
| 2,800,300 | Institution | ― | 3,318,356 | |
| 30,702 | Institution | ― | 36,382 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,735 | Institution | ― | 7,981 | |
| 6,477 | Institution | ― | 7,675 | |
| 13,837 | Institution | ― | 16,397 | |
| 51,140 | Institution | ― | 60,601 | |
| 49,669 | Institution | ― | 58,858 | |
| 70,276 | Institution | ― | 83,277 | |
| 8,555 | Institution | ― | 10,138 | |
| 337 | Institution | ― | 399 | |
| 3,104 | Institution | ― | 3,678 | |
| 78,868 | Institution | ― | 93,459 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Aclaris Therapeutics (GB:0H8T)?
According to the latest TipRanks data, approximately 13.19% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 86.81% is held by retail investors.
What percentage of Aclaris Therapeutics (GB:0H8T) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.19% of Aclaris Therapeutics (GB:0H8T) stock is held by institutional investors.
What percentage of Aclaris Therapeutics (GB:0H8T) stock is held by retail investors?
According to the latest TipRanks data, approximately 86.81% of Aclaris Therapeutics (GB:0H8T) stock is held by retail investors.
Who owns the most shares of Aclaris Therapeutics (GB:0H8T)?
Global X owns the most shares of Aclaris Therapeutics (GB:0H8T).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.